Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$63.06 - $84.75 $217,620 - $292,472
-3,451 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$74.15 - $99.36 $1,853 - $2,484
-25 Reduced 0.72%
3,451 $279,000
Q4 2021

Jan 25, 2022

BUY
$86.01 - $102.89 $7,052 - $8,436
82 Added 2.42%
3,476 $357,000
Q3 2021

Nov 04, 2021

BUY
$84.7 - $96.31 $12,027 - $13,676
142 Added 4.37%
3,394 $297,000
Q2 2021

Aug 09, 2021

SELL
$76.44 - $89.57 $8,331 - $9,763
-109 Reduced 3.24%
3,252 $291,000
Q1 2021

May 14, 2021

SELL
$67.36 - $80.76 $34,151 - $40,945
-507 Reduced 13.11%
3,361 $255,000
Q4 2020

Feb 09, 2021

SELL
$53.08 - $69.86 $10,297 - $13,552
-194 Reduced 4.78%
3,868 $264,000
Q3 2020

Nov 05, 2020

SELL
$51.29 - $65.09 $6,308 - $8,006
-123 Reduced 2.94%
4,062 $216,000
Q2 2020

Jul 30, 2020

SELL
$34.32 - $62.43 $87,653 - $159,446
-2,554 Reduced 37.9%
4,185 $244,000
Q1 2020

May 08, 2020

BUY
$32.64 - $73.63 $99,095 - $223,540
3,036 Added 81.99%
6,739 $266,000
Q4 2019

Feb 06, 2020

SELL
$48.0 - $59.55 $7,824 - $9,706
-163 Reduced 4.22%
3,703 $220,000
Q3 2019

Oct 29, 2019

BUY
$46.64 - $55.39 $180,310 - $214,137
3,866 New
3,866 $206,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.